http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108126198-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5153 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 |
filingDate | 2017-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108126198-B |
titleOfInvention | W18O49-tirapazamine composite nano particle and preparation method and application thereof |
abstract | The invention discloses a W 18 O 49 -tirapazamine composite nanoparticles, which take PEG-PCL as a carrier and are internally loaded with W 18 O 49 And tirapazamine; w 18 O 49 And tirapazamine drug loading of 2.99% and 1.29%, respectively; the composite nano particles are in a dispersed spherical structure, and the particle size is 60-100 nm. The invention can improve the treatment effect of TPZ. |
priorityDate | 2017-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.